uniQure (QURE) Other Non-Current Assets (2015 - 2026)
uniQure (QURE) recorded quarterly Other Non-Current Assets of $5.5 million in Q1 2026, little changed quarter-over-quarter from $5.6 million in Q4 2025, and up 2.08% on a YoY basis from $5.4 million in Q1 2025.
uniQure (QURE) Other Non-Current Assets (2015 - 2026) Analysis & Trends
uniQure's Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $5.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 2.08% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (up 2.08% YoY), while the FY2025 annual figure was $5.6 million, up 297.5% from the prior year.
- Other Non-Current Assets was $5.5 million for Q1 2026 at uniQure, roughly flat from $5.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $38.0 million in Q2 2024 to a low of $1.4 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $7.0 million across 5 years, with a median of $5.6 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 519.92% in 2024, then sank 85.53% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $6.1 million in 2022, then sank by 47.47% to $3.2 million in 2023, then tumbled by 56.06% to $1.4 million in 2024, then jumped by 297.5% to $5.6 million in 2025, then retreated by 0.34% to $5.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $5.5 million (Q1 2026), $5.6 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.54 Mn |
| Dec 31, 2025 | 5.56 Mn |
| Sep 30, 2025 | 5.49 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 37.96 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 6.02 Mn |
| Jun 30, 2023 | 6.12 Mn |
| Mar 31, 2023 | 6.12 Mn |
| Dec 31, 2022 | 6.06 Mn |
| Sep 30, 2022 | 6.09 Mn |
| Jun 30, 2022 | 5.97 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 5.90 Mn |
| Sep 30, 2021 | 5.67 Mn |
| Jun 30, 2021 | 5.76 Mn |